[ad_1]
United States – Scientists in the United States have developed an anticholesic drug and have passed laboratory experiments.
The new drug metabocin was tested in laboratory mice with high fat diets, Metabucin reacts with TRPV1 receptors, a protein known to be part of the body temperature regulation mechanism and the sensation of pain, including heartburn caused by capsaicin at the Society's annual meeting for the study of Ingestive Behavior (SSIB). Located in the pool This substance activates the new receptors of the drug, affecting the white adipose tissue (which is attributed to most adipose tissue of the human body).
Under the influence of capicycine, the white lipid tissue begins to turn into a new fatty fat tissue. That protects the human body from the cold and contributes to the emission of heat. According to scientists, this process helps burn fat and prevent it from accumulating.
During the experiments, scientists added methabucine to the rat food (high in calories) for 8 months. The substance does not force the mice to eat a small amount of food, but at the same time prevents weight gain, increases cholesterol and blood sugar, and there are no side effects on the mice.
Hot foods (chilled with chilli) can not be considered as a way to lose weight because most of the capsaicin that enters the body is not digested, so the foods can not replace the methods used to reduce weight. In receivers.
Source: Rampler
Share this topic:
See current Source Observatory
[ad_2]
Source link
